Treace Medical Concepts (TMCI) Research & Development (2020 - 2026)

Treace Medical Concepts' Research & Development history runs 7 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• Quarterly Research & Development fell 16.9% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.6 million (down 1.96% YoY) and the FY2025 annual result came in at $140.9 million, up 584.25% from the prior year.
• Research & Development was $4.6 million for Q1 2026 at Treace Medical Concepts, down from $37.3 million in the prior quarter.
• Across five years, Research & Development topped out at $40.3 million in Q1 2024 and bottomed at -$60.9 million in Q4 2022.
• A 5-year average of $13.6 million and a median of $5.2 million in 2024 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development tumbled 1903.17% — and 2024, when it soared 1081.95%.
• Treace Medical Concepts' Research & Development stood at -$60.9 million in 2022, then surged by 165.56% to $39.9 million in 2023, then tumbled by 86.95% to $5.2 million in 2024, then soared by 615.03% to $37.3 million in 2025, then tumbled by 87.59% to $4.6 million in 2026.
• Business Quant data shows TMCI's Research & Development at $4.6 million in Q1 2026, $37.3 million in Q4 2025, and $4.7 million in Q3 2025.